Font Size:
a
A
A
Keyword [liposomal irinotecan]
Result: 1 - 2 | Page: 1 of 1
1.
SHR-1316,an Anti-PD-L1 Antibody,plus Chemotherapy As The First-line Treatment For Advanced Esophageal Squamous Cell Carcinoma:a Multi-centre,phase 2 Study
2.
Phase ? Study Of Liposomal Irinotecan(LY01610)in Patients With Advanced Esophageal Squamous Cell Carcinoma
<<First
<Prev Next>
Last>>
Jump to